Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alpha- and beta-blockade in angina pectoris.

S H Taylor

    Drugs
    |January 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Angina pectoris is caused by an oxygen supply-demand imbalance in the heart. Adrenergic blockade, especially beta-blockers, can reduce myocardial oxygen demand and alleviate ischemic pain.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Maximal stomatal conductance to water and plasticity in stomatal traits differ between native and invasive introduced lineages of Phragmites australis in North America.

    AoB PLANTS·2016
    Same author

    Photosynthetic pathway and ecological adaptation explain stomatal trait diversity amongst grasses.

    The New phytologist·2011
    Same author

    Drought limitation of photosynthesis differs between C₃and C₄grass species in a comparative experiment.

    Plant, cell & environment·2010
    Same author

    Effects of chronic hepatitis C infection on the treatment of breast cancer patients.

    Annals of oncology : official journal of the European Society for Medical Oncology·2009
    Same author

    Efficacy and tolerability of amlodipine in the general practice treatment of essential hypertension in an asian multinational population.

    Clinical drug investigation·2008
    Same author

    Social work practice with people with disabilities in the era of disability rights.

    Social work in health care·2001
    Same journal

    Ecnoglutide: First Approvals.

    Drugs·2026
    Same journal

    The Long Road to Long-Acting: What Oral PrEP and CAB-LA Teach Us About Scaling Lenacapavir.

    Drugs·2026
    Same journal

    Botulinum Toxin Type A for Trigeminal and Postherpetic Neuralgia: An Umbrella Review of Systematic Reviews.

    Drugs·2026
    Same journal

    Biologics and Small Molecule Inhibitors: Novel Therapeutic Strategies for Cutaneous Adverse Drug Reactions.

    Drugs·2026
    Same journal

    Use of Sedative-Hypnotic Drugs and the Risk of Developing Alzheimer's Disease: A Systematic Review, Meta-Analysis and Meta-Regression.

    Drugs·2026
    Same journal

    Relacorilant: First Approval.

    Drugs·2026
    See all related articles

    Area of Science:

    • Cardiology
    • Pharmacology

    Background:

    • Angina pectoris arises from myocardial ischemia due to oxygen supply-demand imbalance.
    • Coronary artery disease, often caused by fixed obstructions, is a primary cause of ischemic cardiac pain.
    • Myocardial fibrosis and impaired ventricular function exacerbate symptoms.

    Purpose of the Study:

    • To explore the role of adrenergic blockade in managing angina pectoris.
    • To evaluate the potential benefits and limitations of alpha- and beta-blockade in coronary heart disease.

    Main Methods:

    • Review of the pathophysiology of angina pectoris and the effects of adrenergic stimulation.
    • Analysis of the mechanisms of action for alpha- and beta-adrenoceptor antagonists.

    Main Results:

    Related Experiment Videos

    • Beta-blockers reduce myocardial oxygen consumption by decreasing heart rate and contractility.
    • Alpha-blockade may offer benefits like reduced coronary spasm and afterload but carries risks of hypotension.
    • Combined alpha- and beta-blockade presents a rational approach for coronary heart disease management.

    Conclusions:

    • Beta-blockers are crucial in reducing determinants of myocardial oxygen consumption.
    • Alpha-blockers alone are not indicated for angina, but may be beneficial adjuncts.
    • Targeting adrenergic activity offers a therapeutic strategy for myocardial ischemia.